BRAIN Biotech AG (XTER:BNN) 3-Month Share Buyback Ratio: 0.00% (As of Mar. 2026 )

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:BNN BRAIN Biotech AG XTER:BNN
64 GF Score
Price €2.78
GF Value €2.53
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is BRAIN Biotech AG 3-Month Share Buyback Ratio?

BRAIN Biotech AG XTER:BNN -0.71% 64 3-Month Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus rates XTER:BNN with a GF Score™ of 64/100 and a GF Value™ of €2.53 (Fairly Valued). The stock has 3 warning signs investors should review.

3-Month Share Buyback Ratio only apply to companies whose reporting frequency is 3 months.

XTER:BNN
64GF Score
BRAIN Biotech AG XTER:BNN
3-Month Share Buyback Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a 3-Month Share Buyback Ratio of 0.00 mean?
BRAIN Biotech AG (XTER:BNN) has a 3-Month Share Buyback Ratio of 0.00 as of Mar. 2026. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for BRAIN Biotech AG and its competitors.
Is BRAIN Biotech AG's 3-Month Share Buyback Ratio too high?
BRAIN Biotech AG's current 3-Month Share Buyback Ratio is 0.00. Overall, BRAIN Biotech AG has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BRAIN Biotech AG's 3-Month Share Buyback Ratio compare to LIN and SHW?
BRAIN Biotech AG's 3-Month Share Buyback Ratio of 0.00 can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Month Share Buyback Ratio for a Chemicals company?
A good 3-Month Share Buyback Ratio depends on the Chemicals industry context. However, 3-Month Share Buyback Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Month Share Buyback Ratio mean?
A high 3-Month Share Buyback Ratio can signal that a stock is expensive relative to its fundamentals. The 3-Month Share Buyback Ratio measures the proportion of a company's outstanding shares repurchased over the past three months, calculated as the percentage change in shares outstanding from the previous quarter to the current quarter. View historical data for BRAIN Biotech AG and its competitors. BRAIN Biotech AG's current 3-Month Share Buyback Ratio is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BRAIN Biotech AG stock overvalued right now?
Based on GuruFocus' analysis, BRAIN Biotech AG (XTER:BNN) is currently considered Fairly Valued. The stock's GF Value™ is €2.53, compared to a current price of €2.78 — trading 9.9% above its estimated fair value. The current 3-Month Share Buyback Ratio is 0.00. BRAIN Biotech AG's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Month Share Buyback Ratio calculated?
3-Month Share Buyback Ratio is calculated from a company's financial statements. For BRAIN Biotech AG (XTER:BNN), the current 3-Month Share Buyback Ratio is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BRAIN Biotech AG (XTER:BNN) Overvalued in 2026?

Based on GuruFocus' analysis, BRAIN Biotech AG stock appears to be overvalued. The current stock price of €2.78 is trading 9.9% above its estimated GF Value™ of €2.53. GuruFocus considers BRAIN Biotech AG to be Fairly Valued.

Key valuation signals for XTER:BNN:

  • 3-Month Share Buyback Ratio: 0.00
  • GF Value™: €2.53 vs. price of €2.78 (9.9% above fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the XTER:BNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BRAIN Biotech AG Business Description

Other Exchanges 0RFI:UK
Address Darmstadter Strasse 34-36, Zwingenberg, BW, DEU, 64673
BRAIN Biotech AG is an industrial biotechnology specialist focused on enzyme technology, microbial production strains, and bioprocess design to enable bio-based innovations. The Group conducts research, development, and production for client specifications and its own product portfolio, supporting customers in the food and beverage, chemical, and life sciences industries with solutions that enhance productivity, efficiency, and sustainability. Its operations are organized into two segments: BRAIN Biocatalysts, which develops, produces, and distributes specialty enzymes, microorganisms, and ingredients and generates the majority of revenue, and BRAIN BioIncubator, which focuses on development projects. The company operates in Germany and other countries.
64GF Score

Get the complete analysis for XTER:BNN

3-Month Share Buyback Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.78
Price
€2.53
GF Value